4D Molecular Therapeutics, Inc.
FDMT
$10.45
$0.111.06%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
5/12/2026
-
Tickeron - Stocks
5/11/2026
-
Simply Wall St
5/10/2026
-
The Cerbat Gem
5/10/2026
-
The Cerbat Gem
5/10/2026
-
MarketBeat
5/9/2026
-
MarketBeat
5/8/2026
-
TipRanks Financial Blog
5/8/2026
-
MarketBeat
5/7/2026
-
Zacks Investment Research
5/7/2026
-
Zacks Investment Research
5/7/2026
-
Globe Newswire
5/7/2026
-
Zacks Investment Research
5/7/2026
-
Zacks Investment Research
5/4/2026
-
The Online Investor
5/4/2026
-
Globe Newswire
4/22/2026
-
Tickeron - Stocks
4/22/2026
-
Tickeron - Stocks
4/21/2026
-
MarketBeat
4/17/2026
-
Globe Newswire
4/14/2026
-
Tickeron - Stocks
4/10/2026
-
Zacks Investment Research
4/10/2026
-
Tickeron - Technical Analysis
4/9/2026
-
Tickeron - Technical Analysis
4/1/2026
-
Ticker Report
3/31/2026
-
MarketBeat
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, May 7, 2026
Period Date
Tuesday, March 31, 2026
Next Filing
Week of Aug 10 and 14 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
510 505 2680
Address
5858 Horton Street
EmeryVille, CA 94608
EmeryVille, CA 94608
Country
Year Founded
Business Description
Sector
4D Molecular Therapeutics, Inc., a late-stage biotechnology company, engages in the development of adeno-associated virus vectors from its proprietary synthetic vector discovery platform...
more